Rachel J Hendrix
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Graduate Student Researcher
Research Areas
Biography and Research Information
OverviewAI-generated summary
Rachel J Hendrix's research focuses on acute promyelocytic leukemia (APL). Her recent publication examines the use of isotretinoin during the consolidation phase of APL treatment for patients who have undergone standard all-trans retinoic acid (ATRA)-based induction. This work involved collaboration with Cesar Gentille from the University of Arkansas for Medical Sciences, with whom she has one shared publication. Hendrix's scholarly output includes one publication to date, with her most recent work published in 2026, indicating recent activity in her research pursuits.
Metrics
- Publications: 1
Selected Publications
-
Isotretinoin Use During Consolidation in Acute Promyelocytic Leukemia Following Standard All-Trans Retinoic Acid (ATRA)-Based Induction: A Case Report (2026)
Collaboration Network
Top Collaborators
- Isotretinoin Use During Consolidation in Acute Promyelocytic Leukemia Following Standard All-Trans Retinoic Acid (ATRA)-Based Induction: A Case Report
- Isotretinoin Use During Consolidation in Acute Promyelocytic Leukemia Following Standard All-Trans Retinoic Acid (ATRA)-Based Induction: A Case Report
- Isotretinoin Use During Consolidation in Acute Promyelocytic Leukemia Following Standard All-Trans Retinoic Acid (ATRA)-Based Induction: A Case Report
Similar Researchers
Based on overlapping research topics